Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition for treating leukemia, multiple myeloma, myelodysplastic syndrome

A technology for multiple myeloma and myelodysplasia, which is applied in the field of multiple myeloma, leukemia, and myelodysplastic syndrome compositions. It can solve the problems of difficult disease control, difficult popularization, and single curative effect, and achieve non-toxic Side effects, not easy to repeat, definite curative effect

Active Publication Date: 2011-12-21
北京中科血康血液病医学研究院
View PDF1 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, modern medicine at home and abroad uses chemotherapy and bone marrow transplantation as the main treatment methods, but chemotherapy significantly suppresses the bone marrow and has severe side effects. It is difficult to control the disease due to the influence of many factors such as the age of the patient and the tolerance of the system.
Bone marrow transplantation, limited by bone marrow source matching, age, physical fitness, etc., is difficult to popularize clinically
Zijinding, Liushen Pill, Xihuang Pill and other Chinese patent medicines have single curative effect and slow effect, making it difficult to control such diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0013] 10 grams of Qingdai, 20 grams of Arrowhead Mushroom, 15 grams of Prunella vulgaris, 20 grams of Hedyotis diffusa, 20 grams of Bean Root, 5 grams of Chinese Taxus, 15 grams of Fritillaria, 20 grams of Astragalus, 20 grams of Ligustrum lucidum, Lycium barbarum 15 grams, 20 grams of angelica, 20 grams of raw rehmannia, 20 grams of rehmannia, 15 grams of drynaria, 15 grams of dog ridge, 20 grams of dodder, and 10 grams of safflower.

[0014] Method of administration: decoct in water for 2 times, and take it warmly twice in the morning and evening, add 300-500ml of water each time, and decoct to obtain 150-300ml of medicinal liquid each time.

Embodiment 2

[0016] 6 grams of Qingdai, 15 grams of Arrowhead Mushroom, 15 grams of Prunella vulgaris, 20 grams of Hedyotis diffusa, 20 grams of Bean Root, 5 grams of Chinese Taxus, 15 grams of Fritillaria, 20 grams of Astragalus, 20 grams of Ligustrum lucidum, Lycium barbarum 15 grams, 15 grams of angelica, 15 grams of raw rehmannia, 20 grams of rehmannia, 15 grams of drynaria, 15 grams of dog ridge, 15 grams of dodder, and 15 grams of safflower.

[0017] Dosing method: decoct in water for 2 times, take it warmly twice in the morning and evening, add 300-500ml of water each time, and decoct 150-300ml of medicinal liquid each time.

Embodiment 3

[0019] 10 grams of Qingdai, 20 grams of Arrowhead Mushroom, 15 grams of Prunella vulgaris, 20 grams of Hedyotis diffusa, 20 grams of Bean Root, 5 grams of Chinese Taxus, 15 grams of Fritillaria, 20 grams of Astragalus, 20 grams of Ligustrum lucidum, Lycium barbarum 15 grams, 20 grams of angelica, 20 grams of raw rehmannia, 20 grams of rehmannia, 15 grams of drynaria, 15 grams of dog ridge, 20 grams of dodder, and 15 grams of safflower.

[0020] Method of administration: decoct in water for 2 times, and take it warmly twice in the morning and evening, add 400-600ml of water each time, and decoct 150-300ml of the medicinal solution each time.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a composition for treating leukemia, myeloma multiplex and myelodysplastic syndrome. The composition comprises the following raw materials or extracts thereof: natural indigo, Indian iphigenia bulb, common selfheal fruit-spike, spreading hedyotis herb, vietnamese sophora root, taxus chinensis, thunberg fritillary bulb, astragalus, glossy privet fruit, Chinese wolfberry, Chinese angelica, rehmannia root, prepared rehmannia root, fortune's drynaria rhizome, east asian tree fern rhizome, south dodder seed and safflower. The composition for treating leukemia, myeloma multiplex and myelodysplastic syndrome is definite in a curative effect and quick in response and does not have toxic or side effect, and the leukemia, myeloma multiplex and myelodysplastic syndrome are difficult to relapse.

Description

technical field [0001] The invention relates to a composition for treating leukemia, multiple myeloma and myelodysplastic syndrome. Background technique [0002] Leukemia, multiple myeloma, and myelodysplastic syndrome are based on the body's autoimmune mechanism disorder, gene mutation, and chromosomal abnormalities. Abnormal cloning and differentiation, clinically a group of comprehensive diseases characterized by accumulation of leukemia cells, increased plasma cells, obvious morbid hematopoiesis and anemia. This type of disease is dangerous and difficult to cure, and the mortality rate is high. At present, modern medicine at home and abroad uses chemotherapy and bone marrow transplantation as the main treatment methods, but chemotherapy significantly suppresses the bone marrow and has severe side effects. It is difficult to control the disease due to the influence of many factors such as the age of the patient and the tolerance of the system. Bone marrow transplantatio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/898A61P35/02A61P35/00
Inventor 张广蕊占文琰
Owner 北京中科血康血液病医学研究院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com